These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23168175)

  • 1. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
    Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
    J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
    Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
    Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors.
    Pütz A; Hartmann AA; Fontes PR; Alexandre CO; Silveira DA; Klug SJ; Rabes HM
    Int J Cancer; 2002 Mar; 98(1):99-105. PubMed ID: 11857392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
    Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
    Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
    Kim JW; Cho YH; Lee CG; Kim JH; Kim HK; Kim EJ; Han KT; Namkoong SE
    Acta Oncol; 1997; 36(3):295-300. PubMed ID: 9208900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
    Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
    Regauer S; Kashofer K; Reich O
    Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53 protein in patients with Figo stage III cervix cancer].
    Kainz C; Gitsch G; Joura E; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():116. PubMed ID: 1286309
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
    Wegman P; Ahlin C; Sorbe B
    Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database.
    Li VD; Li KH; Li JT
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):625-636. PubMed ID: 30542790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
    Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
    BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex analysis of the p53 tumor suppressor in lung carcinoma.
    Smardova J; Liskova K; Ravcukova B; Malcikova J; Hausnerova J; Svitakova M; Hrabalkova R; Zlamalikova L; Stano-Kozubik K; Blahakova I; Speldova J; Jarkovsky J; Smarda J
    Oncol Rep; 2016 Mar; 35(3):1859-67. PubMed ID: 26718964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.